Diabetes cost model of a hospital in Thailand

Value in Health

Volumn 10, Issue 4, 2007, Pages 223-230

  Riewpaiboon, Arthorn ^a   Pornlertwadee, Penkae ^b   Pongsawat, Kwanjai ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Samutsongkram Hospital   (Thailand)

Author keywords

Cost model; Diabetes mellitus; Direct medical cost; Hospital; Thailand

Indexed keywords

CYANOCOBALAMIN; GLIBENCLAMIDE; INSULIN; METFORMIN; PYRIDOXINE; THIAMINE; VITAMIN B COMPLEX;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; COST CONTROL; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC PATIENT; DRUG COST; FEMALE; FORECASTING; GANGRENE; HEART MUSCLE ISCHEMIA; HOSPITAL CARE; HOSPITAL COST; HOSPITAL SERVICE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE REGRESSION; NEUROPATHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETINOPATHY; STATISTICAL ANALYSIS; THAILAND;

EID: 34447567077     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00172.x     Document Type: Article

References (53)

1. Unger RH, Foster DW. Diabetes mellitus. In : Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology (9th ed.). Philadelphia, PA : W.B. Saunders, 1998.
2. Kretowski A, Kowalska I, Peczynska J, et al. The large increase in incidence of type I diabetes mellitus in Poland. Diabetologia 2001 44 (Suppl. 3 B48 50.
3. Amos AF, McCarty DI, Zimmet P. The rising global burden and its complications: estimates and projections to the year 2010. Diabet Med 1997 14 (Suppl. S7 85.
4. Zhang P, Engelgau MM, Norris SL, et al. Application of economic analysis to diabetes and diabetes care. Ann Intern Med 2004 140 : 972 7.
5. Ettaro L, Songer TJ, Zhang P, et al. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004 22 : 149 64.
6. Zhou H, Isaman DJ, Messinger S, et al. A computer simulation model of diabetes progression, quality of life, and cost. Diabetes Care 2005 28 : 2856 63.
7. Ray JA, Valentine WJ, Secnik K, et al. Review of the cost of diabetes complications in Australia, Canada,France, Germany, Italy and Spain. Curr Med Res Opin 2005 21 : 1617 29.
8. Grover S, Avasthi A, Bhansali A, et al. Cost of ambulatory care of diabetes mellitus: a study from north India. Postgrad Med J 2005 81 : 391 5.
9. Chodick G, Heymann AD, Wood F, et al. The direct medical cost of diabetes in Israel. Eur J Health Econ 2005 6 : 166 71.
10. Arredondo A, Zuniga A. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. Diabetes Care 2004 27 : 104 9.
11. Ricordeau P, Weill A, Vallier N, et al. The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000? Diabetes Metab 2003 29 : 497 504.
12. The Thai Working Group on Burden Attributable to Risk Factors MoPH. Thailand's Risk Burden in 1999. Bangkok : Bureau of Health Policy and Planning, Ministry of Public Health, 2004.
13. Porapakkham Y, Punyaratabandhu P, eds. The Report of Thailand Population Health Examination Survey III 2003-2004 (in Thai language). Bangkok : Health System Research Institute, 2006.
14. Putsook P. Financial Expenditure of Patients with Diabetes Mellitus [Master of Sciences in Epidemiology]. Bangkok : Mahidol University, 1999.
15. Moolasarn S, Sripa S, Kuessirikiet V, et al. Usage of and cost of complementary/alternative medicine in diabetic patients. J Med Assoc Thai 2005 88 : 1630 7.
16. Kobelt G. Health Economics: An Introduction to Economic Evaluation (2nd ed.). London : Office of Health Economics, 2002.
17. Sridama V. Diabetes Care (in Thai language). Bangkok : Unity Publication, 2000.
18. Drummond MF, O'Brien BJ, Stoddart GL, et al. Methods for the Economic Evaluation of Health Care Programmes (2nd ed.). Oxford : Oxford Medical Publication, 1997.
19. Rigden MS. Health Service Financial and Accounting. London : Heinemann, 1983.
20. Shepard DS, Hodgkin D, Anthony YE. Analysis of Hospital Costs: A Manual for Managers. Geneva : World Health Organization, 2000.
21. Riewpaiboon A. Institutional Cost Analysis. Bangkok : Faculty of Pharmacy, Mahidol University, 2003.
22. Kumaranayake L. The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy Plan 2000 15 : 230 4.
23. Edejer TT-T, Baltussen R, Adam T, et al. Making Choices in Health: WHO, Guide to Cost-Effectiveness Analysis. Geneva : World Health Organization, 2003.
24. Creese A, Parker D. Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva : World Health Organization, 2000.
25. Disyathikom K, Pacharanarumol W, Tangcharoensathien V. A Manual of District Hospital Cost Analysis (in Thai language). Bangkok : International Health Policy Planning, 2001.
26. Lerner WM, Wellman WL, Burik D. Pricing hospital unit of service using micro-costing techniques. Hosp Health Serv Adm 1985 January/February 7 28.
27. Suver JD, Cooper JC. Principles and methods of managerial cost-accounting systems. Am J Hosp Pharm 1988 45 : 146 52.
28. Kumaranayake L, Pepperall J, Goodman H, et al. Costing Guidelines for HIV Prevention Strategies. Geneva, UNAIDS, 2000.
29. Tabachnick BG, Fidell LS. Using Multivariate Statistics (2nd ed.). New York : Harper Collins Publishers, 1989.
30. Cohen J, Cohen P, West SG, et al. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences (3rd ed.). New Jersey : Lawrence Erlbaum Associates, Inc., 2003.
31. Agro KE. Sensitivity analysis in health economic and pharmacoeconomic studies: an appraisal of the literature. Pharmacoecon 1997 11 : 75 88.
32. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Healthecon 1994 3 : 95 401.
33. Briggs A, Sculpher M. Sensitivity analysis in economic evaluation: a review of published studies. Healthecon 1995 4 : 355 71.
34. Afifi AA, Clark V. Computer-Aided Multivariate Analysis. London : Chapman & Hall, 1996.
35. Duan N. Smearing estimator: a nonparametric retransformation method. J Am Statl Assoc 1983 78 : 605 10.
36. Smith M, Barnett P. What is retransformation bias, and how can it be corrected? Available from: http://www.herc.research.med.va.gov/ faqE2_retransformation.pdf [Accessed August 5, 2005].
37. Gencarelli DM. One pill, many prices: variation in prescription drug prices in selected government programs. NHPF Issue Brief 2005 807 : 1 20.
38. Garattini L, Tediosi F, Chiaffarino F, et al. The outpatient cost of diabetes care in Italian diabetes centers. Value Health 2001 4 : 251 7.
39. Palmer AJ, Roze S, Valentine WJ, et al. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004 20 (Suppl. 1 S5 26.
40. O'Brien JA, Patrick AR, Caro JJ. Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res 2003 3 : 7.
41. Morsanutto A, Berto P, Lopatriello S, et al. Major diabetes complications have an impact on total annual medical cost of type 2 diabetes. Diabetes Care 2004 27 : 1841 2.
42. Norlund A, Apelqvist J, Bitzen PO, et al. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 2001 250 : 57 65.
43. Shobhana R, Rao PR, Lavanya A, et al. Cost burden to diabetic patients with foot complications - a study from southern India. J Assoc Physicians India 2000 48 : 1147 50.
44. Shobhana R, Rao PR, Lavanya A, et al. Foot care economics - cost burden to diabetic patients with foot complications: a study from southern India. J Assoc Physicians India 2001 49 : 530 3.
45. Suastika K. Diabetic foot: a major medical, social and economic problem in patients with diabetes. Acta Med Indones 2005 37 : 185 6.
46. Saar WE, Lee TH, Berlet GC. The economic burden of diabetic foot and ankle disorders. Foot Ankle Int 2005 26 : 27 31.
47. Smith D, Cullen MJ, Nolan JJ. The cost of managing diabetic foot ulceration in an Irish hospital. Ir J Med Sci 2004 173 : 89 92.
48. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis 2004 39 (Suppl. 2 S132 9.
49. Girod I, Valensi P, Laforet C, et al. An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients. Diabetes Metab 2003 29 : 269 77.
50. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006 12 : 62 6.
51. Brown JB. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999 159 : 1873 80.
52. Kongsawatt S. Unit Cost of Patient Service 1999, in 5 Provinces under Health Care Reform Project (in Thai language). Bangkok : Monitoring and Evaluation Division, Bureau of Health Policy and Planning, Office of the Permanent Secretary, Ministry of Public Health, 1999.
53. Upakdee N, Pannarunothai S. Medical charges for outpatients: a case study in three provinces using health insurance data (in Thai language). J Health Sci 2003 12 : 775 87.